Spectrum of giant cell vasculitis

Area of Science:

• Rheumatology
• Immunology
• Vascular Medicine

Background:

• Giant cell arteritis (GCA) is the most prevalent primary systemic vasculitis in the United States.
• Severe outcomes of GCA include blindness, stroke, and potentially fatal aortic dissection.
• Current diagnosis relies on temporal artery biopsy, while treatment with corticosteroids causes significant morbidity.

Purpose of the Study:

• To explore Magnetic Resonance Imaging (MRI) as a noninvasive diagnostic and disease assessment tool for GCA.
• To underscore the necessity for identifying steroid-sparing agents through large-scale longitudinal studies.
• To leverage new insights into GCA's immunopathogenesis for targeted therapy development.

Main Methods:

• Review of current diagnostic standards, including temporal artery biopsy.
• Evaluation of Magnetic Resonance Imaging (MRI) for diagnosing GCA and assessing disease activity.
• Analysis of emerging research on GCA immunopathogenesis and cytokine profiles.

Main Results:

• MRI shows potential as a valuable noninvasive method for GCA diagnosis and monitoring.
• Understanding GCA's immunopathogenesis reveals distinct patient subsets with specific cytokine profiles.
• The artery is recognized as an active participant in disease progression, opening avenues for novel therapies.

Conclusions:

• Noninvasive imaging like MRI offers a promising alternative or adjunct to traditional diagnostic methods for GCA.
• Identifying and validating steroid-sparing agents is crucial to mitigate treatment-related morbidity.
• Targeting specific immunopathogenic pathways presents opportunities for developing novel, disease-modifying therapies for GCA.